The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
2.
Doctor Suspected of Murder; Cancer Blood Test Under Fire; TikTok and Body Image
3.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
4.
PFS in R/R Mantle Cell Lymphoma is Improved by Ibrutinib-Venetoclax.
5.
In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.
1.
Mastering Modern Oncology: Accreditation, Education, and Research Trends for 2025
2.
Overcoming Immunotherapy Resistance: Novel Checkpoints, Biomarkers, and Emerging Therapeutic Strategies
3.
Advancing Cancer Treatment: Precision Pharmaceutical Care in Oncohematology
4.
Uncovering the Mystery of the Sessile Serrated Adenoma
5.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
3.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
4.
Current Scenario of Cancer- Final Discussion on the Importance of Genomic Testing & Advancement in Diagnosis and Treatment
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation